PepGen Inc.
NASDAQPEPG arrives at its May 18 clinical update in an unusual position: the stock has dropped 13% over the past week to $1.68, yet short sellers are retreating and Wedbush remains bullish even as it slashes its target for the second time in six weeks. The week's clearest story is the gap between the price action and what short sellers are actually doing. Short interest has fallen…
Snapshot as of 28 Jun 2026
PEPG arrives at its May 18 clinical update in an unusual position: the stock has dropped 13% over the past week to $1.68, yet short sellers are retreating and Wedbush remains bullish even as it slashes its target for…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PEPG — free to start on ORTEX.
Sign up for free →Open PEPG on ORTEX